University of California, Los Angeles
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- Private, Subsidiary
- Established
- 1919-05-23
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ucla.edu
The STOP-HPV Trial 5: Single Arm Evaluation of the Bundle
Not Applicable
- Conditions
- ImmunizationVaccination
- First Posted Date
- 2018-08-01
- Last Posted Date
- 2022-07-05
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 24
- Registration Number
- NCT03609320
- Locations
- ๐บ๐ธ
American Academy of Pediatrics, Itasca, Illinois, United States
The STOP-HPV Trial 6: Single Arm Evaluation of the Maintenance of the STOP-HPV Bundle
Not Applicable
Withdrawn
- Conditions
- VaccinationImmunization
- First Posted Date
- 2018-08-01
- Last Posted Date
- 2023-01-27
- Lead Sponsor
- University of California, Los Angeles
- Registration Number
- NCT03609372
- Locations
- ๐บ๐ธ
American Academy of Pediatrics, Itasca, Illinois, United States
Invasive Approach to Model Human Cortex-Basal Ganglia Action-Regulating Networks
Completed
- Conditions
- Parkinson's Disease Patients Undergoing Deep Brain Stimulation (DBS) Surgery
- Interventions
- Other: Measuring electrical signals from the brain
- First Posted Date
- 2018-07-31
- Last Posted Date
- 2021-10-07
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 27
- Registration Number
- NCT03608228
- Locations
- ๐บ๐ธ
Nader Pouratian, Los Angeles, California, United States
Adolescent Cancer Telemedicine for Pain Management
Not Applicable
Completed
- Conditions
- Cancer
- Interventions
- Behavioral: Telemedicine Pain Management Intervention (waitlist group, intervention administered following 4-week waitlist period)Behavioral: Telemedicine Pain Management Intervention (immediate group)
- First Posted Date
- 2018-07-27
- Last Posted Date
- 2020-11-04
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 10
- Registration Number
- NCT03603886
- Locations
- ๐บ๐ธ
University of California, Los Angeles (UCLA), Los Angeles, California, United States
The STOP-HPV Trial 1: Communication Intervention
Not Applicable
Completed
- Conditions
- ImmunizationVaccination
- Interventions
- Behavioral: STOP-HPV communication intervention
- First Posted Date
- 2018-07-26
- Last Posted Date
- 2024-07-12
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 48
- Registration Number
- NCT03599557
- Locations
- ๐บ๐ธ
American Academy of Pediatrics, Itasca, Illinois, United States
The STOP-HPV Trial 2: Performance Feedback Intervention
Not Applicable
Completed
- Conditions
- ImmunizationVaccination
- Interventions
- Behavioral: STOP-HPV performance feedback intervention
- First Posted Date
- 2018-07-26
- Last Posted Date
- 2020-04-30
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 48
- Registration Number
- NCT03599570
- Locations
- ๐บ๐ธ
American Academy of Pediatrics, Itasca, Illinois, United States
The STOP-HPV Trial 3: Prompts Intervention
Not Applicable
- Conditions
- ImmunizationVaccination
- Interventions
- Behavioral: STOP-HPV prompts intervention
- First Posted Date
- 2018-07-26
- Last Posted Date
- 2022-01-12
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 48
- Registration Number
- NCT03599583
- Locations
- ๐บ๐ธ
American Academy of Pediatrics, Itasca, Illinois, United States
Randomized Controlled Trial of Standard ERP and OC-Go
Not Applicable
Completed
- Conditions
- Obsessive-Compulsive Disorder
- Interventions
- Behavioral: OC-GoBehavioral: Exposure and Response Prevention
- First Posted Date
- 2018-07-26
- Last Posted Date
- 2022-04-11
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 27
- Registration Number
- NCT03601312
- Locations
- ๐บ๐ธ
Univ. of California / Los Angeles / Semel Inst., Los Angeles, California, United States
Ibudilast for the Treatment of Alcohol Use Disorder
Phase 2
Completed
- Conditions
- Alcohol Use Disorder
- Interventions
- Drug: IbudilastDrug: Placebo oral capsule
- First Posted Date
- 2018-07-20
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 102
- Registration Number
- NCT03594435
- Locations
- ๐บ๐ธ
UCLA Addictions Laboratory, Los Angeles, California, United States
A Single-arm Evaluation of the Effect of HCV Treatment on Cardiovascular Disease Risk
Phase 4
Withdrawn
- Conditions
- Hepatitis C
- Interventions
- Drug: Elbasvir/grazoprevir
- First Posted Date
- 2018-07-12
- Last Posted Date
- 2018-08-07
- Lead Sponsor
- University of California, Los Angeles
- Registration Number
- NCT03585101
- Locations
- ๐บ๐ธ
UCLA CARE Center, Los Angeles, California, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath